Synthes Receives FDA-Approval for ProDisc®-C
Synthes Receives FDA Clearance for chronOS™ Strip Flexible Ceramic Osteoconductive Bone Void Filler
Synthes agrees to acquire N Spine to enter the dynamic stabilization market for the lumbar spine
Synthes receives Approvable Letter from FDA for ProDisc™-C (cervical) Total Disc Replacement
Synthes Posts Continued Strong Growth in the Third Quarter 2007
Synthes and Globus agree on settlement
Centers for Medicare and Medicaid Services allows for coverage of Prodisc-L at the discretion of local Medicare directors
Synthes Reports Strong First Half 2007 Financial Results with Sales
up 14.1%, Net Earnings up 16.0%
Resolutions of the 2007 AGM and Announcement of new CEO
Synthes, Inc. Announces Strong First Quarter 2007 Sales Results:
Q1 2007 Sales up 14.2% versus the prior year (11.9% in Local Currency)
Synthes, Inc. Announces Strong Full Year 2006 Financial Results: 2006 Local Currency Sales and Net Earnings up 14.9% and 16.8%, respectively, versus the prior year.
Download Annual Report 2006 >more
January 19, 2007
Synthes Moves to the “UK Exchange Regulated Market” Segment
of the virt-x
